background
influenzalik
ill
ili
estim
caus
million
death
annual
despit
diseas
burden
etiolog
caus
ili
poorli
describ
mani
geograph
region
method
begin
april
conduct
observ
cohort
studi
five
hospit
mexico
citi
enrol
subject
met
criteria
ili
evalu
conduct
enrol
day
collect
clinic
data
nasopharyng
swab
nasal
aspir
children
swab
test
multiplex
pcr
viral
pathogen
realtim
pcr
influenza
result
first
year
subject
enrol
studi
hospit
subject
children
one
pathogen
detect
pcr
subject
commonli
rhinoviru
isol
influenza
isol
six
percent
subject
die
pathogen
identifi
rhinoviru
common
pathogen
among
die
although
highest
case
fatal
rate
conclus
multipl
respiratori
virus
beyond
influenza
associ
signific
morbid
mortal
among
adult
children
mexico
citi
detect
agent
could
use
adjust
antibiot
treatment
sever
case
april
outbreak
respiratori
diseas
young
peopl
report
mexico
citi
etiolog
agent
identifi
influenza
viru
outbreak
consequ
compel
ministri
health
mexico
us
nation
institut
allergi
infecti
diseas
niaid
collabor
establish
mexican
emerg
infecti
diseas
clinic
research
network
la
red
acut
respiratori
infect
estim
caus
million
death
annual
mani
influenzalik
ill
ili
etiolog
ili
mexican
individu
seek
medic
care
welldefin
report
popul
multipl
respiratori
virus
parainfluenza
viru
rhinoviru
adenoviru
metapneumoviru
respiratori
syncyti
viru
rsv
coronaviru
caus
ili
virolog
etiolog
vari
greatli
among
geograph
local
age
group
season
year
studi
suggest
specif
symptom
could
use
clinic
predict
etiolog
ili
though
studi
compar
influenza
noninfluenza
etiolog
although
outcom
subject
infect
variou
influenza
subtyp
well
document
rel
littl
descript
outcom
viral
etiolog
ili
shlomai
et
al
compar
outcom
hospit
ili
found
mortal
influenza
patient
vs
influenzaneg
ili
patient
demonstr
burden
noninfluenza
etiolog
agent
contribut
ili
widmer
et
al
report
rsv
hospit
rate
exceed
influenza
per
respect
import
know
characterist
season
behavior
differ
type
viru
caus
ili
although
current
clinic
diagnost
test
virus
high
cost
improv
diagnosi
would
allow
judici
use
empir
widespectrum
antibiot
treatment
mani
case
could
suspend
thu
reduc
cost
hospit
recogn
need
investig
influenza
noninfluenza
ili
mexican
popul
la
red
implement
studi
object
describ
etiolog
symptom
outcom
subject
present
ili
mexico
citi
begin
april
hospitalbas
observ
cohort
studi
conduct
five
hospit
mexico
citi
hospit
locat
south
mexico
citi
includ
gener
hospit
tertiari
care
hospit
serv
mainli
respiratori
problem
tertiari
care
hospit
serv
metabolicsurg
popul
two
pediatr
center
center
chosen
given
capac
conduct
clinic
research
studi
popul
includ
subject
age
month
present
ili
ili
defin
presenc
least
one
respiratori
symptom
eg
short
breath
postnas
drip
cough
one
two
follow
criteria
fever
method
examin
participantreport
fever
feverish
past
h
one
nonrespiratori
symptom
eg
malais
headach
myalgia
chest
pain
subject
includ
sought
medic
attent
center
agre
particip
studi
demograph
data
collect
enrol
nasopharyng
swab
copan
brescia
itali
nasal
aspir
children
obtain
pcr
detect
respiratori
pathogen
sampl
storag
sampl
place
transport
medium
maintain
sent
within
h
central
facil
molecular
biolog
laboratori
infecti
diseas
depart
innsz
mexico
citi
store
clinic
laboratori
test
carri
enrol
avail
result
test
taken
standard
clinic
care
chest
xray
bacteriolog
cultur
arteri
blood
gase
liver
test
also
abstract
medic
record
subject
seen
day
followup
inform
also
obtain
phone
day
visit
clinic
inform
symptom
chronic
medic
condit
previou
treatment
impact
daili
function
hospit
death
assess
sampl
test
realtim
revers
transcriptas
pcr
influenza
follow
center
diseas
control
prevent
cdc
protocol
cdc
describ
previous
multipathogen
detect
sampl
test
kit
previous
respifind
plu
pathofind
bv
maastricht
netherland
describ
previous
multiplex
pcr
test
detect
differenti
virus
coronaviru
human
metapneumoviru
influenza
influenza
influenza
b
parainfluenza
viru
type
rsv
b
rhinoviru
adenoviru
well
four
bacteria
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
analyt
sensit
report
manufactur
vari
copi
per
reaction
target
sampl
discord
realtim
revers
transcriptas
pcr
result
multiplex
pcr
influenza
sampl
test
third
method
base
finalpoint
nest
pcr
protocol
sampl
result
test
consid
final
result
data
analyz
statist
analysi
system
sa
institut
cari
nc
usa
median
rang
percentag
use
summar
quantit
qualit
variabl
respect
discard
role
chanc
mannwhitney
test
chisquar
fisher
exact
test
use
appropri
univari
logist
regress
analys
perform
evalu
effect
baselin
covari
risk
death
odd
ratio
correspond
confid
interv
ci
report
base
fit
logist
regress
model
pvalu
twosid
correct
multipl
comparison
p
consid
statist
signific
april
april
subject
enrol
studi
total
withdrew
withdrawn
studi
figur
characterist
studi
particip
list
tabl
quarter
studi
subject
children
femal
four
hundr
thirtysix
subject
hospit
asthma
cardiovascular
diseas
common
chronic
medic
condit
though
neither
condit
account
subject
total
etiolog
agent
identifi
among
total
subject
pathogen
isol
rhinoviru
frequent
isol
pathogen
infect
enrol
subject
account
isol
rhinoviru
follow
influenza
detect
subject
isol
adenoviru
coronaviru
metapneumoviru
rsv
isol
frequenc
greater
pathogen
detect
subject
tabl
among
subject
mix
viru
infect
uniqu
combin
record
common
combin
adenovirusrhinoviru
nine
subject
combin
adenovirusmetapneumoviru
eight
subject
influenza
bmetapneumoviru
eight
subject
influenza
common
viru
involv
coinfect
consid
subtyp
present
combin
combin
limit
two
virus
four
common
pathogen
rhinoviru
influenza
coronaviru
rsv
season
distribut
isol
observ
cooler
month
decembermarch
season
variat
rhinoviru
rsv
howev
less
pronounc
coronaviru
influenza
figur
april
novemb
rhinoviru
account
ili
howev
decemb
march
period
total
number
ili
case
increas
rel
contribut
rhinoviru
ili
previou
influenza
vaccin
report
children
adult
found
differ
proport
vaccin
unvaccin
subject
person
viru
without
viru
detect
neither
individu
agent
group
evalu
across
four
common
pathogen
show
children
like
fever
product
cough
nausea
wherea
adult
like
fatigu
headach
sore
throat
tabl
respiratori
symptom
dyspnea
common
among
rhinoviru
rsv
gastrointestin
symptom
nausea
diarrhea
common
among
influenza
hospit
requir
subject
tabl
lower
percentag
subject
infect
coronaviru
influenza
hospit
infect
rhinoviru
rsv
respect
tabl
pediatr
popul
rsv
infect
highest
rate
hospit
well
highest
absolut
number
hospit
n
hospit
pediatr
subject
mix
infect
n
rhinoviru
n
influenza
n
also
contribut
significantli
hospit
pediatr
cohort
rhinoviru
also
common
pathogen
isol
adult
elderli
hospit
follow
mix
infect
influenza
metapneumoviru
patient
enrol
die
patient
die
pathogen
identifi
rhinoviru
common
etiolog
agent
identifi
subject
die
death
pathogen
identifi
death
four
pediatr
subject
die
two
rsv
one
parainfluenza
one
mycoplasma
subject
year
age
infect
coronaviru
influenza
metapneumoviru
rhinoviru
rsv
mortal
rate
exceed
highest
mortal
rate
n
seen
cohort
patient
year
old
identifi
pathogen
follow
rhinoviru
mix
viral
infect
appreci
larger
rate
hospit
death
subject
die
like
elev
creatinin
lactat
dehydrogenas
creactiv
protein
lower
lymphocyt
count
higher
neutrophil
count
tabl
subject
die
like
underli
medic
condit
except
asthma
subject
system
steroid
prior
enrol
also
like
die
headach
sore
throat
seen
commonli
nonfat
case
wherea
rale
repres
lower
respiratori
tract
diseas
like
fatal
case
product
cough
seem
differenti
fatal
nonfat
case
studi
present
thorough
descript
caus
ili
mexico
citi
date
use
multiplex
pcr
test
one
pathogen
identifi
enrol
subject
common
pathogen
identifi
studi
rhinoviru
isol
influenza
second
common
pathogen
isol
consist
seri
adult
ili
variou
geograph
region
rhinoviru
report
account
adult
ili
isol
influenza
coronaviru
commonli
also
also
signific
contributor
burden
ili
isol
recent
studi
report
coronaviru
third
fifth
common
pathogen
among
children
studi
common
pathogen
influenza
follow
rsv
rhinoviru
similar
signific
contribut
rsv
influenza
note
prior
studi
rhinoviru
howev
rare
test
previou
studi
one
prospect
cohort
studi
children
lower
respiratori
tract
infect
rhinoviru
report
second
rsv
caus
hospit
frequenc
isol
hospit
children
suggest
rhinoviru
previous
underappreci
pathogen
age
group
rhinoviru
caus
signific
morbid
age
group
studi
popul
individu
infect
rhinoviru
requir
hospit
rhinoviru
also
common
isol
subject
die
isol
subject
given
studi
design
clear
attribut
caus
hospit
death
possibl
coronaviru
speci
made
isol
popul
coronaviru
present
similar
syndrom
influenza
twentytwo
percent
subject
isol
coronaviru
hospit
popul
age
year
increas
studi
design
preclud
determin
exact
hospit
rate
result
coronaviru
infect
hospit
rate
similar
influenza
pathogen
identifi
subject
common
adult
pathogen
detect
adult
subject
age
year
children
pathogen
detect
subject
unclear
subject
bacteri
infect
pathogen
test
assay
noninfecti
etiolog
ili
unfortun
lack
pair
sputum
limit
abil
determin
etiolog
cohort
new
caledonia
pair
sputum
sampl
requir
determin
etiolog
agent
subject
lower
respiratori
tract
infect
popul
hospit
children
mexico
lower
respiratori
tract
infect
viral
etiolog
determin
studi
found
virolog
agent
children
improv
detect
like
part
due
extend
panel
virus
test
multiplex
pcr
one
viru
isol
subject
possibl
determin
contribut
viru
clinic
syndrom
possibl
determin
virus
detect
caus
diseas
pcr
significantli
improv
sensit
detect
respiratori
virus
detect
viral
nucleic
acid
may
alway
repres
causat
prior
casecontrol
studi
viru
nucleic
acid
could
isol
asymptomat
subject
might
support
data
show
among
mix
infect
outcom
significantli
wors
subject
singl
infect
subject
enrol
symptomat
would
increas
likelihood
isol
pathogen
caus
cohort
studi
abl
directli
determin
causat
uniqu
combin
differ
subject
assess
outcom
lack
statist
power
determin
differ
variou
combin
mix
infect
determin
noninfluenza
respiratori
virus
ili
sever
implic
first
increas
knowledg
acut
respiratori
ill
associ
morbid
often
caus
respiratori
virus
may
stimul
develop
afford
rapid
diagnost
test
well
therapeut
virus
consider
increas
antibiot
resist
diagnosi
respiratori
virus
could
decreas
quantiti
empir
broadspectrum
antibiot
use
aim
studi
epidemiolog
surveil
respiratori
diseas
includ
patient
sever
ill
sought
medic
attent
attend
physician
determin
need
hospit
outpati
treatment
limit
popul
particular
group
patient
clinic
manifest
diseas
strategi
seek
find
seriou
case
believ
easili
determin
factor
associ
sever
diseas
limit
studi
howev
lose
part
popul
mild
asymptomat
diseas
conclus
virus
tradit
believ
produc
minor
diseas
capac
certain
subject
caus
sever
case
suggest
high
proport
adult
patient
rhinoviru
infect
requir
inhospit
treatment
believ
find
mark
need
specif
studi
help
us
better
understand
behavior
virus
factor
associ
seriou
present
nation
cancer
institut
nation
institut
health
contract
content
public
necessarili
reflect
view
polici
depart
health
human
servic
westat
mention
trade
name
commerci
product
organ
impli
endors
us
govern
ethic
approv
ethic
committe
institut
review
studi
studi
conduct
follow
principl
ich
gcp
declar
helsinki
mexican
gener
health
law
subject
provid
inform
consent
data
deidentifi
data
collect
project
regist
clinicaltrialsgov
conflict
interest
author
compet
interest
declar
